[ad_1]
The government of São Paulo will present the Coronavac vaccine registration request to the National Health Surveillance Agency (Anvisa) this week, with more than 90% proven effectiveness. This is what propagates to members of the São Paulo government listened to by CNN. The request would be made last Tuesday but was postponed for a week. It is time to complete the investigation, deliver more complete material and claim the registration also in Anvisa Chinese, which has not yet come out.
This index may put Coronavac ahead, for example, of AstraZeneca’s vaccine, produced in association with the University of Oxford, which had to retest due to variation in effectiveness.
Pfizer’s vaccine, for example, achieved a 95% yield, while Moderna’s is 94.5%.
Officially, the São Paulo government has avoided setting a number.
The Butantan Institute said, in a note, that the results of the effectiveness of the vaccine will only be presented on December 23. “Any information on the index before that date is mere speculation,” he says.
“Butantan maintains its firm commitment to science, backed by 120 years of services in favor of life. We reiterate that all the press will be duly informed about the efficacy index of the vaccine, based on real data ”, the note adds.
To date, no manufacturer has submitted an emergency use application or vaccine registration with Anvisa.
From the moment this request is submitted, the agency is committed to providing a response within 10 days.
Additional charges
By the end of this year, 10 million doses of the vaccine will have reached Brazil, via São Paulo. It is more than the initial forecast.
Another shipment of 11 million doses will arrive in late January.
